Results 151 to 160 of about 175,055 (304)

Tailoring the Properties of Functional Materials With N‐Oxides

open access: yesAdvanced Functional Materials, EarlyView.
The properties of materials bearing N‐oxide groups are often dominated by the polar N+─O− bond. It provides hydrophilicity, selective ion‐binding, electric conductivity, or antifouling properties. Many of the underlying mechanisms have only recently been discovered, and the interest in N‐oxide materials is rapidly growing.
Timo Friedrich   +5 more
wiley   +1 more source

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents

open access: gold, 2013
Ying-Qian Liu   +11 more
openalex   +2 more sources

Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy

open access: yesAdvanced Functional Materials, EarlyView.
A bimetallic Mn–Ca nanoreactor (MCC) is developed as a non‐nucleotide STING nanoagonist for cancer metalloimmunotherapy. MCC induces Ca2+ overload and hydroxyl radical generation, resulting in mitochondrial damage and mtDNA release. The released mtDNA cooperates with Mn2+ to robustly activate cGAS–STING signaling.
Xin Wang Mo   +7 more
wiley   +1 more source

Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals

open access: yesAdvanced Functional Materials, EarlyView.
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee   +4 more
wiley   +1 more source

Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agentsviabone-marrow-derived cells [PDF]

open access: green, 2023
Huining You   +6 more
openalex   +1 more source

Efectos de la manipulación de los fármacos citostáticos en el personal sanitario [PDF]

open access: yes, 2018
[ES] Introducción: la toxicidad de los fármacos citostáticos utilizados en el tratamiento del cáncer afecta no sólo a los pacientes, sino a la salud de los trabajadores que lo manipulan.
Clerencia Casado, Iván
core  

Home - About - Disclaimer - Privacy